Evidence map›Paper›PMID 42421667›Full record

ArticleNature chemical engineering2026

Hybrid bioprinting of hierarchical vascular networks at capillary-scale resolution.

Yuxuan Liao, Salvador Gallegos-Martínez, Xiao Kuang, Yipu Du, Yu Shrike Zhang, Yanliang Zhang

Abstract read
In one paragraph

Article in Nature chemical engineering, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yuxuan LiaoDepartment of Aerospace and Mechanical Engineering, University of Notre Dame, Notre Dame, IN 46556, USA.
Salvador Gallegos-MartínezDivision of Engineering in Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Cambridge, MA 02139, USA.
Xiao KuangDivision of Engineering in Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Cambridge, MA 02139, USA.
Yipu DuDepartment of Aerospace and Mechanical Engineering, University of Notre Dame, Notre Dame, IN 46556, USA.
Yu Shrike ZhangDivision of Engineering in Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Cambridge, MA 02139, USA.
Yanliang ZhangDepartment of Aerospace and Mechanical Engineering, University of Notre Dame, Notre Dame, IN 46556, USA.

Funding

High-throughput Imaging-integrated Vascular Model for Understanding Thromboembolism and Therapeutics ScreeningR01HL166522 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI Junjie Yao, Y. Shrike Zhang · 2023 to 2026
$2.7M
Biomaterials for embolization and ablation of arterio-venous malformationsR01HL165176 · NHLBI · MAYO CLINIC ARIZONA · PI OKLU, RAHMI, ZHANG, Y. SHRIKE · 2022 to 2025
$2.6M
Stretchable Hydrogel Bioinks-Enabled Microfluidic Bioprinting of Functional Small-Diameter Blood VesselsR01HL153857 · NHLBI · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI ZHAO, XUANHE · 2020 to 2024
$2.4M
High-Throughput Volumetric Photoacoustic Imaging of Living Vascularized OrganoidsR01EB028143 · NIBIB · DUKE UNIVERSITY · PI YAO, JUNJIE · 2019 to 2022
$2.0M
"Clinical Trials" on a Premature Vascular Aging-on-a-Chip ModelUH3TR003274 · NCATS · BRIGHAM AND WOMEN'S HOSPITAL · PI ZHANG, Y. SHRIKE · 2022 to 2024
$1.8M
A Bioprinted Volumetric Model of Vascularized GlioblastomaR01CA282451 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · PI Kaisorn Lee Chaichana, Y. Shrike Zhang · 2023 to 2026
$1.7M
Development of An Optoelectronically Active BioinkR21EB030257 · NIBIB · UNIVERSITY OF HOUSTON · PI YU, CUNJIANG · 2020 to 2020
$694k
Autonomous Hybrid Bioprinting of Hierarchical Perfusable Vascularized Liver TissuesR01EB038366 · NIBIB · UNIVERSITY OF NOTRE DAME · PI Yanliang Zhang · 2026 to 2026
$663k
Cryobioprinting for Shelf-Ready Tissue Fabrication and StorageR56EB034702 · NIBIB · BRIGHAM AND WOMEN'S HOSPITAL · PI ZHANG, Y. SHRIKE · 2023 to 2023
$499k
NCATS NIH HHS UH3 TR003274NCI NIH HHS R01 CA282451NHLBI NIH HHS R01 HL153857NHLBI NIH HHS R01 HL165176NHLBI NIH HHS R01 HL166522NIBIB NIH HHS R01 EB028143NIBIB NIH HHS R01 EB038366NIBIB NIH HHS R21 EB030257NIBIB NIH HHS R56 EB034702
6 · The paper itself

Abstract

Replicating the intricate hierarchical architecture of natural vascular networks, especially at capillary-scale resolution, remains a pivotal challenge in organ fabrication. Here we present a machine learning-enhanced hybrid bioprinting strategy that combines high-resolution aerosol jet printing of sacrificial materials and high-throughput extrusion printing of tissue matrices. This integrated approach enables sub-10 μm of resolution, achieving capillary-like channels and allowing on-demand modulation of vessel diameters in real time. Constrained Bayesian optimization rapidly identify optimal printing parameters, ensuring reliable, high-fidelity attainment of target channel sizes without exhaustive trial-and-error. This streamlined workflow supports the fabrication from 1D conduits to 3D multibranch hierarchical networks with tunable geometries. Endothelial cells seeded into these channels form continuous, functional monolayers, significantly reducing permeability while maintaining high cell viability and proliferation. By transcending the resolution limits of conventional sacrificial printing, this bioprinting method establishes a new route for producing biomimetic vasculature. Its unique combination of rapid optimization, real-time tunability, and microcapillary-scale precision holds exceptional promise for tissue engineering, regenerative medicine, and drug discovery.

Identifiers

PMID42421667
PMCPMC13344490

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.